top of page


Where C-Suite Members Engage in Building High-Performance Leadership

​​The invitation-only Vanguard Forums bring together C-suite leaders in a uniquely enriching dialogue with each other and a faculty of peers, top-tier CEOs, board members, and other experts. 

Together, the participants share what works – and what does not – along with perspectives on leadership opportunities and challenges across their sectors.

The Forums develop critical top leadership insights, skills, and capabilities through pragmatic learnings not found via conventional conferences or business school offerings.


The Forum leadership experience is just one aspect of a Vanguard Network membership. Monthly events for members allow C-Suite leaders to share experiences and network with peers in a private, by-invitation only space.

Vanguard NEXT
Play Video

Typical Session Topics

  • Building High Performance Teams and Cultures

  • Leading in the Accelerating and Converging Environment: Building New Competencies and Capabilities

  • Managing Board Relations in an Era of Shareholder Activism

  • Learning and Adopting Best Practices from Other Companies and Industries

  • Workshop: Creating Your Company Narrative

  • Cultivating a Culture of Digital Innovation: New Strategies on Leadership and Talent to Shape the Future of Your Industry

Who is Eligible to Participate?

Vanguard Forum delegates include CEOs, C-Suite executives and Board Members from across the global business ecosystem.

Becoming a Forum Delegate

Delegates are accepted into the Vanguard Forums in two ways. The Forums extend direct invitations to high talent individuals identified by the advisory boards, faculty members and industry leaders.

The Member Company program enables organizations to integrate the Forums into their executive development process. Member companies have the privilege of consulting on the Forum agendas and ongoing curriculum, as well as preferred pricing. To learn more, contact us.


A select number of industry-leading organizations are invited to collaborate on Vanguard Forums and other monthly activities. While conventional acknowledgment and branding opportunities are available, sponsor-partners may also:

  • provide input into the program and meeting structure

  • assume roles as moderators or faculty members

  • influence faculty and delegate invitations

  • contribute to the ongoing curriculum

To explore partnership opportunities, please contact us

Vanguard Forum Advisors and Faculty/Session Leaders

  • Goran Ando - Chairman, Novo Nordisk

  • Bob Bailey - Executive Vice President and General Counsel, Allergan

  • Cheryl Beebe - Board member Convergys, past EVP and CFO of Ingredion

  • Jeff Berkowitz - Executive Vice President, UnitedHealth Group

  • Orlan Boston - Global Life Sciences & Healthcare Senior Partner, EY

  • Tony Coles - Chairman and CEO, Yumanity; past CEO, Onyx

  • Stephen Cutler - Partner, Simpson Thacher & Bartlett LLP

  • Tanuja Dehne - Board Member, past EVP NRG Energy

  • Cynthia Dow - Leader, Global Legal, Regulatory & Compliance Officers Practice, Russell Reynolds Associates

  • Mike Farrar - Former Chief Executive, NHS Confederation

  • Eliot Forster - Chair of MedCity (London) and CEO, ImmunoCore

  • Mark Goodman - Partner, Debevoise & Plimpton LLP

  • Beatrice Grech-Cumbo - Senior Client Partner, Korn Ferry

  • Ed Greissing - Executive director of the Lynda and Stewart Resnick Center for Public Health, Milken Institute

  • Fred Hassan - Managing Director, Warburg Pincus; past CEO, Schering Plough

  • Mary Ann Hynes - Senior Counsel, Dentons; career General Counsel

  • Garrick Isert - President, Executas; past M.D. of World 50, Inc.

  • Bob Jansen - CEO, Zensights

  • Trevor Jones OBE - Visiting Professor, King’s College, London

  • Will Kane - SVP, US Branded Pharma, Internal Medicine Brands, Allergan

  • Mehmood Khan - Vice Chairman & Chief Scientific Officer, PepsiCo

  • Bob Langer - MIT Professor; U.S. Medal of Science awardee; global leader integrating biotech and materials science

  • Jeremy Levin - Chairman and CEO, Ovid; past CEO, Teva Pharmaceuticals

  • Ashley McEvoy - Group Company Chairman, J&J

  • David Nash - Founding Dean, Jefferson College of Population Health

  • Mark Pfister - M A Pfister Strategy Group; Board Advisor

  • Ronald T. Piervincenzi - CEO, USP

  • David Pyott - Board Member, Philips; past Chairman and CEO, Allergan

  • Vivek Ramaswamy - Founder and CEO, Roivant Sciences, Inc.; founder and past CEO, Axovant Sciences

  • Tom Sabatino - Executive Vice President and General Counsel, Aetna; past GC of Hertz, United Airlines, Walgreens, Schering-Plough, Baxter

  • Brent Saunders - Chairman and CEO, Allergan

  • Craig B. Thompson MD - President and CEO, Memorial Sloan Kettering Cancer Center

  • David Toung - Analyst, Argus

  • Chris Viehbacher - Managing Partner, Gurnet Point Capital; past CEO, Sanofi

  • Michael Watras - CEO, Straightline World

bottom of page